Emily Rose Curfman

Emily Curfman practices at Roswell Park Cancer Institute in Los Angeles, California.

Emily Curfman's NPI, 1477112555, was assigned on June 11, 2019. Emily Curfman holds New York license 023711.

Emily Curfman's primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.

Emily Curfman's primary practice is Roswell Park Cancer Institute in Los Angeles, California. Emily Curfman is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Roswell Park Comprehensive Cancer Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Emily Curfman practices. Vendor and product names are available with a free account.

Physician assistant is Emily Curfman's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Emily Curfman is licensed in New York.

CMS counts 101 Medicare patients who saw Emily Curfman in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have cancer, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Emily Curfman's median patient age at 70, with 53% women.

In 2024, Emily Curfman wrote 1,139 Medicare Part D claims for 256 patients. 72% of them were for generic drugs.

Emily Curfman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Emily Curfman from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $253.